Cite

HARVARD Citation

    Dronca, R. et al. (2015). Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record